Methods of treating an ocular disease or disorder

US11723982B2 · kind B2 · utility

Assignee

• The Regents of the University of California · US

Inventors

• Kevin E. Healy · Moraga, US
• Eda Isil Altiok · Berkeley, US
• David V. Schaffer · Danville, US
• Wesley M. Jackson · Albany, US

Key dates

• Filing date: Aug 5, 2020
• Grant date: Aug 15, 2023
• Expiry date: May 13, 2041

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/622
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure provides methods of treating an ocular disease or disorder. The methods involve direct administration into the eye of a conjugate comprising a biologically active polypeptide and a biocompatible polymer.